The report by GlobalData, a data and analytics company, showed that the global burden of 12-month diagnosed prevalent cases ...

The US FDA has approved Vtama 1% cream for the topical treatment of atopic dermatitis in adult and pediatric patients aged 2 ...

Approval of the topical aryl hydrocarbon receptor agonist was supported by the pivotal ADORING studies. In the ...

A study revealed that parents of children with atopic dermatitis experience less than optimal sleep and are more reliant on ...

Korean researchers link indoor mold toxins to worsening atopic dermatitis in dogs Indoor air pollutants may contribute to the ...

The global prevalence of atopic dermatitis -- a chronic skin condition -- is expected to reach 42.42 million by 2033, ...

With over 1,100 subjects enrolled across 39 clinical study sites, the company is developing and validating the study.

Artificial Intelligence (AI) can be a great tool in diagnosing and management of atopic dermatitis -- a chronic skin conditi ...

In the era of artificial intelligence (AI), various trends have been observed that utilize AI in multiple sectors, having a ...

The US Food and Drug Administration (FDA) has approved nemolizumab for moderate-to-severe atopic dermatitis inadequately ...

Corvus Pharmaceuticals' stock plummeted ~40% after Phase 1 data for soquelitinib in AD showed mixed results. See why I ...

The FDA has blessed two previously approved medicines—one a cream and the other an injection—to treat atopic dermatitis (AD).